Sex: F
Vaccine: COVID19
Symptoms: Arthritis, Inflammation, Pain
Clinical narrative: Inflammation in ring/pinky finger/middle finger; Body aches; Inflammation in right ankle; This spontaneous case was reported by a consumer and describes the occurrence of INFLAMMATION (Inflammation in ring/pinky finger/middle finger), PAIN (Body aches) and ARTHRITIS (Inflammation in right ankle) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Psoriatic arthritis and Rheumatoid arthritis.    Concurrent medical conditions included Psoriatic arthritis and Rheumatoid arthritis.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced INFLAMMATION (Inflammation in ring/pinky finger/middle finger), PAIN (Body aches) and ARTHRITIS (Inflammation in right ankle). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INFLAMMATION (Inflammation in ring/pinky finger/middle finger) and ARTHRITIS (Inflammation in right ankle) outcome was unknown and PAIN (Body aches) had resolved.            No concomitant medications were reported.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.    Causality for HUMIRA (ADALIMUMAB) The reporter's causality for the event (s) INFLAMMATION IN RING/ PINKY FINGERS/MIDDLE FINGER and INFLAMMATION IN RIGHT ANKLE was not provided.  The reporter's causality for the event (s) of HUMIRA IS NOT WORKING and BODY ACHE with HUMIRA (ADALIMUMAB) was no reasonable possibility. Company comment: This spontaneous case concerns an adult female patient, with medical history of Psoriatic arthritis and Rheumatoid arthritis, who experienced the unexpected, non-serious of ARTHRITIS (reported as Inflammation in right ankle).  The event was reported with no onset date; hence latency to the 3 doses of mRNA-1273 vaccine cannot be assessed. As per source document, she was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency, and the event had resolved on an unknown date. The history of Psoriatic arthritis, Rheumatoid arthritis, and the co-suspect ADALIMUMAB (HUMIRA) remain as confounders for the event. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This spontaneous case concerns an adult female patient, with medical history of Psoriatic arthritis and Rheumatoid arthritis, who experienced the unexpected, non-serious of ARTHRITIS (reported as Inflammation in right ankle).  The event was reported with no onset date; hence latency to the 3 doses of mRNA-1273 vaccine cannot be assessed. As per source document, she was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency, and the event had resolved on an unknown date. The history of Psoriatic arthritis, Rheumatoid arthritis, and the co-suspect ADALIMUMAB (HUMIRA) remain as confounders for the event. The benefit-risk relationship of mRNA-1273 is not affected by this report.